Tag Archives: NASDAQ:QDEL

Quidel (QDEL) Gets a Buy Rating from Canaccord Genuity

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Quidel (QDEL – Research Report) yesterday and set a price target of $75.00. The company’s shares closed last Monday at $64.19. According to TipRanks.com, Massaro is a top 100 analyst

Quidel Corp (QDEL) Initiated with a Buy at Canaccord Genuity

Quidel Corp (QDEL – Research Report) received a Buy rating and a $70 price target from Canaccord Genuity analyst Mark Massaro on June 26. The company’s shares closed on Friday at $59.32. According to TipRanks.com, Massaro is a top 100

Analysts Are Bullish on These Healthcare Stocks: Quidel Corp (QDEL), Biohaven Pharmaceutical Holding Co Ltd (BHVN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Quidel Corp (QDEL – Research Report) and Biohaven Pharmaceutical Holding Co Ltd (BHVN – Research Report) with bullish sentiments. Quidel Corp (QDEL)

The S.V.P., N.A. Commercial Ops of Quidel Corp is Exercising Options

Yesterday it was reported that the S.V.P., N.A. Commercial Ops of Quidel Corp (QDEL – Research Report), Russell Edward Keith, exercised options to sell 13,000 QDEL shares at $15.40 a share, for a total transaction value of $839.7K. In addition

A Director at Quidel Corp (NASDAQ: QDEL) is Selling Shares

Yesterday, a Director at Quidel Corp (QDEL – Research Report), Mary Lake Polan, sold shares of QDEL for $896.8K. Following Mary Lake Polan’s last QDEL Sell transaction on February 07, 2019, the stock climbed by 11.1%. See today’s analyst top

Barclays Maintains Their Buy Rating on Quidel Corp (QDEL)

Barclays analyst Jack Meehan maintained a Buy rating on Quidel Corp (QDEL – Research Report) yesterday and set a price target of $74. The company’s shares closed yesterday at $64.30. According to TipRanks.com, Meehan is a 4-star analyst with an